Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS

Author： Uckun Fatih M   Cahn Pedro   Qazi Sanjive   D'Cruz Osmond  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.4, 2012-04, pp. : 489-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretroviral-based microbicides and oral pre-exposure prophylaxis for HIV prevention

By Ramjee Gita  

Future Virology, Vol. 6, Iss. 8, 2011-08 ,pp. : 997-1014

Future Medicine

Access to resources Recommend Favorite

Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherence

By Blumenthal Jill  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 13, 2013-09 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

Tenofovir-based HIV pre-exposure prophylaxis

By Paxton Lynn A  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1207-1218

Future Medicine

Access to resources Recommend Favorite

Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives

By  

Current Pharmaceutical Design, Vol. 23, Iss. 18, 2017-07 ,pp. : 2579-2591

Bentham Science Publishers

Access to resources Recommend Favorite

The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS

By Anis A.H.  

PharmacoEconomics, Vol. 18, Iss. 4, 2000-10 ,pp. : 393-404

Adis International

Access to resources Recommend Favorite